Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sincrolab is a digital health company based in Madrid, Spain, specializing in the development of digital therapeutics for neurocognitive disorders. The company's core product is an artificial intelligence-driven platform that delivers personalized cognitive stimulation through gamified exercises. By analyzing patient performance in real-time, the AI adjusts the difficulty and type of tasks to optimize therapeutic outcomes for conditions such as ADHD, stroke recovery, and neurodegenerative diseases. Sincrolab's solutions are designed to be used under clinical supervision, providing healthcare professionals with data-driven insights into patient progress and treatment efficacy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sincrolab.